Wan, Shanshan
Kim, Tae Hyun
Smith, Kaylee J. http://orcid.org/0000-0003-1479-6102
Delaney, Ryan
Park, G-Su
Guo, Hui
Lin, Eric http://orcid.org/0000-0001-7571-1657
Plegue, Thomas
Kuo, Ning
Steffes, John
Leu, Christopher
Simeone, Diane M.
Razimulava, Nataliya
Parikh, Neehar D. http://orcid.org/0000-0002-5874-9933
Nagrath, Sunitha http://orcid.org/0000-0002-1497-7977
Welling, Theodore H.
Funding for this research was provided by:
Translational Oncology Program, University of Michigan
National Science Foundation
Article History
Received: 24 May 2019
Accepted: 21 November 2019
First Online: 9 December 2019
Competing interests
: Dr. Theodore Welling has been funded by Merck; He has advisory role for Bristol-Myers Squibb and received compensation. Dr. Diane M. Simeone has been funded by Immunovia; She is on the advisory boards for Interpace and Nybo Therapeutics and received compensation. Dr. Neehar D. Parikh has been funded by Bayer, Exact Sciences and Target Pharmasolutions; He is on the advisory boards for Bayer, Eisai and Wako Diagnostics; He also has consulted for Bristol-Myers Squibb and Exelixis; All other authors declare no competing interests.